Author

Marta Bermejo‐Jambrina

Innsbruck Medical UniversityORCID 0000-0003-1931-6913Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

Doris WilflingsederiD· 1 shared Godelieve J. de BreeiD· 1 shared John L. van HammeiD· 1 shared Lieve E. H. van der DonkiD· 1 shared Maria PrinsiD· 1 shared Marit J. van GilsiD· 1 shared Menno D. de JongiD· 1 shared Neeltje A. KootstraiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Doris WilflingsederORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyThe EMBO JournalPeer-reviewedFeb 28, 2024

Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2

Marta Bermejo‐Jambrina, Lieve E. H. van der Donk, John L. van Hamme…·Teunis B. H. Geijtenbeek

This study shows that antibodies against SARS-CoV-2 reduce complement-induced inflammation, suggesting a role for complement in immune activation and antibody-mediated immune regulation.

4 citations

humanproteomics

𝕏 PostBluesky